ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2"
Episode Synopsis
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.
Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence on targeted therapies, immunotherapies, and combination regimens, as well as practical considerations for sequencing and selecting therapies. Gain actionable insights to enhance collaborative care and deliver the most effective, individualized treatment plans for your patients. Listen now!
Click here to claim credit for this activity: https://bit.ly/3HtOziO
Click here to listen to Module 1 of this series: https://bit.ly/45u106o
Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence on targeted therapies, immunotherapies, and combination regimens, as well as practical considerations for sequencing and selecting therapies. Gain actionable insights to enhance collaborative care and deliver the most effective, individualized treatment plans for your patients. Listen now!
Click here to claim credit for this activity: https://bit.ly/3HtOziO
Click here to listen to Module 1 of this series: https://bit.ly/45u106o
More episodes of the podcast Oncology Data Advisor
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
02/10/2025
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
11/08/2025
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2
07/08/2025
In God we trust